BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6147364)

  • 21. Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.
    Azula FJ; Alzola ES; Conde M; Trueba M; Macarulla JM; Marino A
    Mol Pharmacol; 1996 Aug; 50(2):367-79. PubMed ID: 8700145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
    Dunkern TR; Hatzelmann A
    Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in the guanylate cyclase activity of human thrombocytes during ADP-inducible aggregation].
    Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
    Biull Eksp Biol Med; 1991 Feb; 111(2):152-4. PubMed ID: 1677293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
    Raz A
    Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
    Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble guanylyl cyclase is the only enzyme responsible for cyclic guanosine monophosphate synthesis in human platelets.
    Gambaryan S; Subramanian H; Rukoyatkina N; Herterich S; Walter U
    Thromb Haemost; 2013 May; 109(5):973-5. PubMed ID: 23467662
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of cyclic adenosine monophosphate and guanosine monophosphate on the aggregation and nucleotide metabolism of the blood platelets].
    Nikulin AA
    Farmakol Toksikol; 1978; 41(2):177-82. PubMed ID: 207563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of aggregation inducers and inhibitors on the pentosephosphate pathway enzymes of glucose conversion in the thrombocytes].
    Nikulin AA; Aksenova VM; Petrovich IuA
    Farmakol Toksikol; 1979; 42(3):254-7. PubMed ID: 221244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris.
    Chirkov YY; Chirkova LP; Horowitz JD
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):520-5. PubMed ID: 8897457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic GMP binding and cyclic GMP phosphodiesterase in rat platelets.
    Hamet P; Coquil JF
    J Cyclic Nucleotide Res; 1978 Aug; 4(4):281-90. PubMed ID: 82561
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelet aggregation and cyclic nucleotide phosphodiesterase activity in arteriosclerotic patients.
    Yamazaki H; Motomiya T; Mashimo N; Asano T; Hidaka H
    Thromb Haemost; 1978 Feb; 39(1):158-66. PubMed ID: 205971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
    Hidaka H; Asano T
    J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 35. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
    Kikura M; Kazama T; Ikeda T; Sato S
    Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of beta 2-glycoprotein-I upon the content of cAMP and cGMP in human blood platelets.
    Nimpf J; Gries A; Wurm H; Kostner GM
    Thromb Haemost; 1985 Dec; 54(4):824-7. PubMed ID: 3003956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of mitomycin C on platelet aggregation and adenosine 3',5'-monophosphate metabolism.
    Hashimoto S; Shibata S; Kobayashi B
    Thromb Haemost; 1978 Feb; 39(1):177-85. PubMed ID: 205972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of guanylate cyclase and phosphodiesterases in the functional heterogeneity of human blood platelet subpopulations.
    Opper C; Schrumpf E; Gear AR; Wesemann W
    Thromb Res; 1995 Dec; 80(6):461-70. PubMed ID: 8610274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro effect of thymic epithelial culture supernate on cyclic GMP levels in rabbit platelets.
    Hashimoto S; Mase A; Mizuno Y; Muraoka M; Tsuchiya M
    Thymus; 1990 Feb; 15(1):47-55. PubMed ID: 1970675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in activating ability of human platelet guanylate cyclase during aggregation.
    Severina IS; Belushkina NN
    Biochem Int; 1992 Dec; 28(4):621-31. PubMed ID: 1362351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.